[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20040268L - Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen - Google Patents

Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen

Info

Publication number
NO20040268L
NO20040268L NO20040268A NO20040268A NO20040268L NO 20040268 L NO20040268 L NO 20040268L NO 20040268 A NO20040268 A NO 20040268A NO 20040268 A NO20040268 A NO 20040268A NO 20040268 L NO20040268 L NO 20040268L
Authority
NO
Norway
Prior art keywords
pyridazine
derivatives
preparation
new
methods
Prior art date
Application number
NO20040268A
Other languages
English (en)
Other versions
NO326155B1 (no
Inventor
Aniko Miklosne Kovacs
Istvan Gacsalyi
Jozsef Barkoczy
Janos Wellmann
Katalin Pallagi
Peter Kotay Nagy
Gyorgy Levay
Andras Egyed
Gyula Simig
Judit Raczne Bajnogel
Eva Schmidt
Gabor Szenasi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO20040268L publication Critical patent/NO20040268L/no
Publication of NO326155B1 publication Critical patent/NO326155B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040268A 2001-07-26 2004-01-20 2H-pyridazin-3-onderivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen, anvendelse som medikamenter og farmasoytiske preparater NO326155B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0103063A HU225955B1 (en) 2001-07-26 2001-07-26 Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
PCT/HU2002/000072 WO2003010166A1 (en) 2001-07-26 2002-07-24 Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient

Publications (2)

Publication Number Publication Date
NO20040268L true NO20040268L (no) 2004-03-23
NO326155B1 NO326155B1 (no) 2008-10-13

Family

ID=89979562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040268A NO326155B1 (no) 2001-07-26 2004-01-20 2H-pyridazin-3-onderivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen, anvendelse som medikamenter og farmasoytiske preparater

Country Status (28)

Country Link
US (1) US7098210B2 (no)
EP (1) EP1417206B1 (no)
JP (1) JP4249012B2 (no)
KR (1) KR100909514B1 (no)
CN (1) CN1247571C (no)
AR (2) AR036248A1 (no)
AT (1) ATE466859T1 (no)
AU (1) AU2002321669B8 (no)
BR (1) BR0211440A (no)
CA (1) CA2453917C (no)
CY (1) CY1110240T1 (no)
CZ (1) CZ2004123A3 (no)
DE (1) DE60236294D1 (no)
DK (1) DK1417206T3 (no)
EA (1) EA006246B1 (no)
ES (1) ES2345541T3 (no)
HK (1) HK1067626A1 (no)
HU (1) HU225955B1 (no)
MA (1) MA27867A1 (no)
MX (1) MXPA04000814A (no)
NO (1) NO326155B1 (no)
NZ (1) NZ531154A (no)
PL (1) PL206824B1 (no)
PT (1) PT1417206E (no)
SI (1) SI1417206T1 (no)
SK (1) SK552004A3 (no)
WO (1) WO2003010166A1 (no)
ZA (1) ZA200400482B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227255B1 (en) 2002-04-26 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
KR20080032072A (ko) 2005-06-08 2008-04-14 이그니스 이노베이션 인크. 발광 디바이스 디스플레이 구동 방법 및 시스템
KR20090006057A (ko) 2006-01-09 2009-01-14 이그니스 이노베이션 인크. 능동 매트릭스 디스플레이 회로 구동 방법 및 시스템
US9269322B2 (en) 2006-01-09 2016-02-23 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
US9489891B2 (en) 2006-01-09 2016-11-08 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
WO2009127065A1 (en) 2008-04-18 2009-10-22 Ignis Innovation Inc. System and driving method for light emitting device display
CA2637343A1 (en) 2008-07-29 2010-01-29 Ignis Innovation Inc. Improving the display source driver
US9370075B2 (en) 2008-12-09 2016-06-14 Ignis Innovation Inc. System and method for fast compensation programming of pixels in a display
US8283967B2 (en) 2009-11-12 2012-10-09 Ignis Innovation Inc. Stable current source for system integration to display substrate
CA2687631A1 (en) 2009-12-06 2011-06-06 Ignis Innovation Inc Low power driving scheme for display applications
CA2696778A1 (en) 2010-03-17 2011-09-17 Ignis Innovation Inc. Lifetime, uniformity, parameter extraction methods
US9351368B2 (en) 2013-03-08 2016-05-24 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US20140368491A1 (en) 2013-03-08 2014-12-18 Ignis Innovation Inc. Pixel circuits for amoled displays
US9886899B2 (en) 2011-05-17 2018-02-06 Ignis Innovation Inc. Pixel Circuits for AMOLED displays
EP2945147B1 (en) 2011-05-28 2018-08-01 Ignis Innovation Inc. Method for fast compensation programming of pixels in a display
US9747834B2 (en) 2012-05-11 2017-08-29 Ignis Innovation Inc. Pixel circuits including feedback capacitors and reset capacitors, and display systems therefore
US9786223B2 (en) 2012-12-11 2017-10-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9336717B2 (en) 2012-12-11 2016-05-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
WO2014124755A1 (de) 2013-02-18 2014-08-21 Jürgen Von Der Ohe Verfahren und vorrichtung zum kaltstrahlreinigen
CA2894717A1 (en) 2015-06-19 2016-12-19 Ignis Innovation Inc. Optoelectronic device characterization in array with shared sense line
US9721505B2 (en) 2013-03-08 2017-08-01 Ignis Innovation Inc. Pixel circuits for AMOLED displays
CA2873476A1 (en) 2014-12-08 2016-06-08 Ignis Innovation Inc. Smart-pixel display architecture
CA2886862A1 (en) 2015-04-01 2016-10-01 Ignis Innovation Inc. Adjusting display brightness for avoiding overheating and/or accelerated aging
US10373554B2 (en) 2015-07-24 2019-08-06 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2898282A1 (en) 2015-07-24 2017-01-24 Ignis Innovation Inc. Hybrid calibration of current sources for current biased voltage progra mmed (cbvp) displays
US10657895B2 (en) 2015-07-24 2020-05-19 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2908285A1 (en) 2015-10-14 2017-04-14 Ignis Innovation Inc. Driver with multiple color pixel structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
JP2004538293A (ja) 2004-12-24
US20040171619A1 (en) 2004-09-02
JP4249012B2 (ja) 2009-04-02
CN1545513A (zh) 2004-11-10
CN1247571C (zh) 2006-03-29
ES2345541T3 (es) 2010-09-27
SI1417206T1 (sl) 2010-09-30
AU2002321669B8 (en) 2008-06-05
EA200400223A1 (ru) 2004-12-30
PL367447A1 (en) 2005-02-21
DE60236294D1 (de) 2010-06-17
HK1067626A1 (en) 2005-04-15
AU2002321669B2 (en) 2008-05-15
CY1110240T1 (el) 2015-01-14
DK1417206T3 (da) 2010-08-16
EP1417206A1 (en) 2004-05-12
KR20040030862A (ko) 2004-04-09
PL206824B1 (pl) 2010-09-30
AR088808A2 (es) 2014-07-10
KR100909514B1 (ko) 2009-07-27
NZ531154A (en) 2005-09-30
ATE466859T1 (de) 2010-05-15
EP1417206B1 (en) 2010-05-05
BR0211440A (pt) 2004-07-20
EA006246B1 (ru) 2005-10-27
PT1417206E (pt) 2010-07-29
HU0103063D0 (en) 2001-10-28
HUP0103063A2 (hu) 2003-02-28
CZ2004123A3 (cs) 2004-05-12
ZA200400482B (en) 2005-05-25
CA2453917A1 (en) 2003-02-06
AU2002321669A2 (en) 2003-02-17
SK552004A3 (en) 2004-08-03
AR036248A1 (es) 2004-08-25
US7098210B2 (en) 2006-08-29
CA2453917C (en) 2009-06-23
HUP0103063A3 (en) 2005-06-28
MA27867A1 (fr) 2006-05-02
MXPA04000814A (es) 2004-05-21
HU225955B1 (en) 2008-01-28
NO326155B1 (no) 2008-10-13
WO2003010166A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO996433L (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
LTC1345910I2 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
NO20021599D0 (no) Nye farmasöytiske sammensetninger av anti-tuberkulose legemidler og fremgangsmåte for deres fremstilling
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO20042805L (no) Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
DK1414816T3 (da) Stabil polymorf af flibanserin, teknisk fremgangsmåde til fremstilling deraf og anvendelse deraf til lægemiddelfremstilling
NO20010031D0 (no) Derivater av 2-aminopyridiner, anvendelse av dem som medikamenter og farmasöytiske preparater inneholdende dem
EE05385B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
NO20035163D0 (no) Nye piperidinkarboksamid-derivater, fremgangsmåte for deres fremstilling ogfarmasöytiske preparater inneholdende de samme
NO20014632L (no) Nye morfolinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende de nevnte derivater
NO20034985L (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
EE200300065A (et) Meetod peptiidsoolade valmistamiseks, nende peptiidsoolade kasutamine ning neid peptiidsooli sisaldavad farmatseutilised preparaadid
EE200300436A (et) Imidasolidiini derivaadid, nende valmistamine ja kasutamine põletikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
NO20021527D0 (no) Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel
NO20015617L (no) Spiroimidazolderivater, deres fremstilling, deres anvendelse og farmasöytiske preparater som innbefatter slike derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees